Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Case report; a case of septic pulmonary embolism driven by direct communication between the right coronary artery and the right atrium].
Hirai K, Yokouchi H, Nikaido T, Inokoshi Y, Fukuhara N, Mizukami H, Tanino YN, Ishida T, Takeishi Y, Munakata M. Hirai K, et al. Among authors: yokouchi h. Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3615-7. doi: 10.2169/naika.100.3615. Nihon Naika Gakkai Zasshi. 2011. PMID: 22338891 Japanese. No abstract available.
Analysis of the response and toxicity to gefitinib of non-small cell lung cancer.
Konishi J, Yamazaki K, Kinoshita I, Isobe H, Ogura S, Sekine S, Ishida T, Takashima R, Nakadate M, Nishikawa S, Hattori T, Asahina H, Imura M, Kikuchi E, Kikuchi J, Shinagawa N, Yokouchi H, Munakata M, Dosaka-Akita H, Nishimura M. Konishi J, et al. Among authors: yokouchi h. Anticancer Res. 2005 Jan-Feb;25(1B):435-41. Anticancer Res. 2005. PMID: 15816608 Free article.
Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.
Kanazawa K, Yokouchi H, Wang X, Ishida T, Fujita Y, Fujiuchi S, Harada T, Harada M, Takamura K, Oizumi S, Kinoshita I, Katsuura Y, Honjo O, Kojima T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M; Hokkaido Lung Cancer Clinical Study Group. Kanazawa K, et al. Among authors: yokouchi h. Cancer Chemother Pharmacol. 2014 Dec;74(6):1149-57. doi: 10.1007/s00280-014-2589-3. Epub 2014 Oct 8. Cancer Chemother Pharmacol. 2014. PMID: 25294632 Clinical Trial.
Multicentric Castleman's disease with impaired lymphocytic apoptosis.
Minemura H, Ikeda K, Tanino Y, Hashimoto Y, Nikaido T, Fukuhara A, Yokouchi H, Sato S, Tanino M, Oka T, Hebisawa A, Suzuki H, Ogawa K, Takeishi Y, Munakata M. Minemura H, et al. Among authors: yokouchi h. Allergol Int. 2015 Jan;64(1):112-4. doi: 10.1016/j.alit.2014.08.009. Epub 2014 Dec 18. Allergol Int. 2015. PMID: 25572569 Free article. No abstract available.
A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer.
Minemura H, Yokouchi H, Azuma K, Hirai K, Sekine S, Oshima K, Kanazawa K, Tanino Y, Inokoshi Y, Ishii T, Katsuura Y, Oishi A, Ishida T, Munakata M. Minemura H, et al. Among authors: yokouchi h. BMC Res Notes. 2015 Jun 5;8:220. doi: 10.1186/s13104-015-1214-9. BMC Res Notes. 2015. PMID: 26043909 Free PMC article. Clinical Trial.
325 results